The University of Southampton
University of Southampton Institutional Repository

Thiol-mediated generation of nitric oxide accounts for the vasodilator action of furoxans

Thiol-mediated generation of nitric oxide accounts for the vasodilator action of furoxans
Thiol-mediated generation of nitric oxide accounts for the vasodilator action of furoxans
Furoxans (1,2,5-oxadiazole-2-oxides) are widely used in organic chemistry as intermediate compounds for the synthesis of various heterocycles. Despite the fact that some furoxans have been found to possess remarkable biological activities, up to now no systematic study on their mode of action has been reported. The aim of the present study was to investigate the molecular mode of the vasodilator action of furoxans. Furoxans, but not the corresponding furazans, concentration-dependently increased coronary flow in an isolated working rat heart preparation. This effect was blunted upon coinfusion with methylene blue. All tested furoxans were demonstrated to increase potently the activity of soluble guanylate cyclase. Enzyme stimulation was found to be mediated by the generation of nitric oxide (NO) following chemical reaction of the furoxans with sulfhydryl groups of low molecular weight thiols and proteins. Furoxans are thus prodrugs which increase the level of cyclic GMP via formation of NO and may therefore be classified as nitrovasodilators. Along with the generation of NO, nitrite and nitrate ions and S-nitrosothiols were formed. The rates of formation of these metabolites, however, did not appear to be related to enzyme stimulation. A tentative reaction scheme that fits the obtained experimental data is proposed. Recently reported cytotoxic, mutagenic, immunosuppressive and anticancer effects of furoxans are discussed in the light of their ability to release NO upon reaction with thiols.
0006-2952
1149-1157
Feelisch, Martin
8c1b9965-8614-4e85-b2c6-458a2e17eafd
Schönafingeri, Karl
584c3228-ee77-4e93-b32c-f34de058fa5c
Noack, Eike
dd3b6e9e-226e-4941-8d70-1c876d41fa50
Feelisch, Martin
8c1b9965-8614-4e85-b2c6-458a2e17eafd
Schönafingeri, Karl
584c3228-ee77-4e93-b32c-f34de058fa5c
Noack, Eike
dd3b6e9e-226e-4941-8d70-1c876d41fa50

Feelisch, Martin, Schönafingeri, Karl and Noack, Eike (1992) Thiol-mediated generation of nitric oxide accounts for the vasodilator action of furoxans. Biochemical Pharmacology, 44 (6), 1149-1157. (doi:10.1016/0006-2952(92)90379-w). (PMID:1358072)

Record type: Article

Abstract

Furoxans (1,2,5-oxadiazole-2-oxides) are widely used in organic chemistry as intermediate compounds for the synthesis of various heterocycles. Despite the fact that some furoxans have been found to possess remarkable biological activities, up to now no systematic study on their mode of action has been reported. The aim of the present study was to investigate the molecular mode of the vasodilator action of furoxans. Furoxans, but not the corresponding furazans, concentration-dependently increased coronary flow in an isolated working rat heart preparation. This effect was blunted upon coinfusion with methylene blue. All tested furoxans were demonstrated to increase potently the activity of soluble guanylate cyclase. Enzyme stimulation was found to be mediated by the generation of nitric oxide (NO) following chemical reaction of the furoxans with sulfhydryl groups of low molecular weight thiols and proteins. Furoxans are thus prodrugs which increase the level of cyclic GMP via formation of NO and may therefore be classified as nitrovasodilators. Along with the generation of NO, nitrite and nitrate ions and S-nitrosothiols were formed. The rates of formation of these metabolites, however, did not appear to be related to enzyme stimulation. A tentative reaction scheme that fits the obtained experimental data is proposed. Recently reported cytotoxic, mutagenic, immunosuppressive and anticancer effects of furoxans are discussed in the light of their ability to release NO upon reaction with thiols.

Other
1992 Feelisch-Biochem Pharmacol.PDF - Other
Download (1MB)

More information

Published date: 25 September 1992
Organisations: Clinical & Experimental Sciences

Identifiers

Local EPrints ID: 337912
URI: http://eprints.soton.ac.uk/id/eprint/337912
ISSN: 0006-2952
PURE UUID: fe8e3c21-df73-44af-9a1c-dcc17ac7125d
ORCID for Martin Feelisch: ORCID iD orcid.org/0000-0003-2320-1158

Catalogue record

Date deposited: 20 Jun 2012 11:58
Last modified: 15 Mar 2024 03:42

Export record

Altmetrics

Contributors

Author: Martin Feelisch ORCID iD
Author: Karl Schönafingeri
Author: Eike Noack

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×